Fevertree Drinks Share Discussion Threads

[wetdream] 07/11/2017 22:32

Devalpha-agree.
I don't think you can take a downmarket brand like Schweppes, upmarket.
A good comparison might be the car market.
Toyota used the Lexus; Nissan used Infiniti; and Ford used(bought)Aston Martin.
Also harking back to the 'good old days of 1783' represents lack of imagination imho.

[wetdream] 07/11/2017 22:23

Imho all this competitor activity just expands FT's market sector.
Only bit missing at the moment is how successful their US activity has been so far.

[devalpha] 07/11/2017 21:33

I think the new Schweppes premium mixers range may significantly harm their standard offering and ultimately work in Fever - Tree's favour. For me FT have a clear strategy....premium mixers. Schweppes seem to be going after the premium while still leaving their classic range alongside. Punters will be confused.

[sogoesit] 07/11/2017 21:13

It seems that Schhh 1783 Tonic is selling at £20.99 for 24x200ml bottles thus 87.45p per 200ml bottle.
FT in Waitrose is selling its Indian Tonic at £3.00 for 4x200ml thus 75p per bottle.
Surprising!!!
(I haven’t been tracking this but the price comparison seems to indicate that Schhh are trying to differentiate themselves as quite a high end “Premium”;). We will have to wait and see how that pans out.
Correct me if I’m wrong... as I find that price differential quite surprising.

[sogoesit] 07/11/2017 20:59

Guys, this is my understanding:
FT say that they are responsible for 97% of the “value growth” in retail. Since it’s in the same sentence I assume this is in the “mixer category” or segment.
So, if in 2016 this segment had total sales of £100 and in 2017 it, say, doubled to £200, FT are saying they are responsible for £97 of the incremental £100 in 2017.

On the issue of segmenting and monopoly it seems that the market is currently categorised as “drinks mixers”. If, however, one segmented this overall market into Premium Mixers and Bog Standard Mixers then there would be 2 new segments. (This is easily done on price... and possibly categorising other segments too).
So, if a few years ago, there was no Premium segment then it would be reasonable to argue that FT created this (market) and monopolised it 100%. Seeing that this, new, segment was highly profitable would induce other players to enter the market, like Schhh(it) with 1783, and emulate that concept. They might not price themselves at exactly the same level but they would be close. (I haven’t checked to see what 1783 retails at so cant say but I’m guessing). If successful the incursion of these new players would dilute FT’s market share from its original 100%. But it could still dominate. The key indicators to look for are market size growth, share of market and discounting as this story unfolds.
[By the way I am not a retail marketer and nor do I have any experience in retail. I am just a keen observer and fascinated by Markets and Pricing of all sorts. I did used to market natural gas tho! Lol]

[martywidget] 07/11/2017 20:36

Panic Investor, thanks for your snippit. Why not buy the tonic (or maybe better still ask for a free sample in store), taste it, give us your findings. If it's better, no matter how much money you have, then buy it and save yourself some money. [Oh, now let's see, if everyone did that! Oops!]

[wetdream] 07/11/2017 19:35

The co. pretty much repeat earlier advice, 'ahead of/exceed market expectations' and the share price rises £3.
So....was the drop to £18.50 then up to £19.60 just nerves? MMs taking the p!ss?
Cos nothing much has changed!
;-)

[martywidget] 07/11/2017 19:27

Can Red Bull stop the Fever-Tree train?
7 November 2017

...The success of Fever-Tree has not gone unnoticed at Red Bull's Austrian headquarters... The company has recently unveiled its own premium mixers range, Organics by Red Bull. Initially launched in Austria, we can expect the four-strong range - including a tonic variant - to be rolled out far and wide. Organics has likely been timed to head off Fever-Tree before it gets its tentacles too deeply into the European and North American markets.

Red Bull certainly knows about the mixer markets, having created its reputation as a mixer in its early days. In many markets, most consumer's first exposure to Red Bull was mixing it with vodka in a bar or a club. The 'Vodka Red Bull' barcall remains popular today, as does the Jägerbomb and other Red Bull alcoholic combinations.

Red Bull could undoubtedly provide some competition for Fever-Tree but the antidote is to be one step ahead...

[panic investor] 07/11/2017 18:16

@waitrose have introduced their own tonics - over half the price of #FEVR and using #FEVR shelf space in Surrey Presume they will all be at it - who's producing it ?Haven't tasted it as the other half would kill me if I didn't by Fever

[martywidget] 07/11/2017 16:02

[Just as a reminder] , so people don't keep asking the same questions elsewhere:


...Perry cider producer Brothers Drinks, which is owned by the Showering family, which created Babysham and manufactures and bottles Fever-Tree drinks for the brand owner...

[martywidget] 07/11/2017 15:10

Fever-Tree boss in for the long haul as shares fizz on rosy outlook
7 November 2017 • 1:33pm

The co-founder and chief executive of posh tonic maker Fever-Tree has said he is not thinking about succession planning after 12 years at the top as the company again looks set to smash profit expectations.

Tim Warrillow...said he was “as enthusiastic, if not more so, than ever”...

...Far from being a saturated market in the UK, Mr Warrillow said Fever-Tree was now being sold in more hotels, bars, restaurants and retailers.

He added supermarkets were also making more space on their shelves for Fever-Tree and had started opening up hallowed ‘secondary space’ - such as the end of aisles or standalone displays usually reserved for the fastest-selling products...

...Mr Warrillow said the company had witnessed 80 competitors launch globally since it started in 2005 and even large players in developed markets such as Schweppes and Britvic had not gained as much traction as commentators might have expected.

Fever-Tree is now in 70 countries and while there were intentions to enter more...

{Full article here}:

[martywidget] 07/11/2017 13:34

Fever-Tree soars after fifth profit upgrade in a year
Shares in drinks mixer maker jump 10% as they stage next leg of rally that has taken them more than 1,000% higher since flotation three years ago.
by Daniel Grote on Nov 07, 2017 at 11:19


Hawksmoor: bubble warning on AIM's soaraway 'AbFab' stocks
By Danielle Levy 07 Nov, 2017 at 07:15

[panic investor] 07/11/2017 12:53

Sorry juzzer- would like to know the regions where Schweppes are in bars still - Surrey definitely not !

[juzzer100] 07/11/2017 12:50

Panic - yes I know it is growth!!By market data I mean publicly available data about the market. I was responding to the comment by SoGo about how you could segment a market and to achieve 100% for ones own aims. Schweppes still number 1 to my knowledge... or FT would have said something for sure.

[martywidget] 07/11/2017 12:39

On-Trade:

From the presentation on July 25 2017:

Strong consistent growth in On-Trade, footprint increased to 20.8k outlets






07 November, 2017

Off-trade:

...Rival Schweppes continues to be the top brand, with off-trade sales totalling £68.2 million, but Fever-Tree is snapping at its heels.

So much so, that if the pioneering mixers brand, which saw sales soar by £27.6 million – a 14% jump – to £46.4 million in the past year, can continue to grow at even half this level, it will be competing for the number one brand position in the off-trade next year (IRI 52 w/e to 22 July, 2017)...




New analyst price targets from earlier today etc over here:

Fevertree Drinks PLC (Fever-Tree)

[panic investor] 07/11/2017 12:06

Large I would say - I only know of one pub in my area that stocks Schweppes and that place still does silver service and is stuck in the 80's - only stocks 2 gins

[privileged] 07/11/2017 11:59

any idea what their market share is now?

[panic investor] 07/11/2017 11:56

If it were market share the others would have gone bust !

[panic investor] 07/11/2017 11:54

Guys it's 97% growth not market share

[juzzer100] 07/11/2017 11:42

Sogo - i assume the 97% is market data, and would be very surprised if FT are massaging the figure!

[nimrod22] 07/11/2017 10:28

back up through 50 dma

[martywidget] 07/11/2017 10:23

Unstoppable Fevertree’s fizzing again
07 November 2017, 10:05

...Investec Securities explains: 'A driving force has been a very strong performance in the UK Having reported over 100% UK growth in the previous four half year periods, we had expected some degree of slowing, but growth has continued at a very healthy level in both the on- and off-trade.'

...‘For the full year, we expect the UK to grow by over 70% still. Despite some noise around competitor activity, Fever-Tree has been responsible for 97% of the growth in the UK retail mixer category over the previous 12 months (according to market data to the end of the third quarter).’...

...Shore Capital, analyst Phil Carroll writes: ‘Fevertree has issued a short trading update stating that strong momentum has continued across the business but especially in the UK and notably not in this instance as a function of distribution gains but more through strong rates of sales.’...

...Investec Securities’ Nicola Mallard reiterates her ‘buy’ rating and increases her Fevertree price target from £22.20 to £23.30. For 2017, Mallard’s top line forecast rises 6% to £158.3m (2016: £102.2m) – that’s 55% year-on-year revenue growth - but her pre-tax profit (PBT) estimate is upgraded by 11% to £54.5m (2016: £35m) ‘thanks to operational gearing benefits’.

For 2018, Mallard sees pre-tax profit bubbling higher still to £55.9m, though Fevertree’s sales growth rate is expected to slow to 15%, with earnings per share forecast to increase from 37.8p to 38.5p.

Shore Capital is ‘upgrading our forecasts which are already ahead of consensus going into today’s statement. Full year 2017 forecast revenue will increase to £158m from £154m but the leverage impact through the income statement is strong with PBT increasing to £53.3m from £50.5m. This equates to an increase in EPS of 6% to 37.4p from 35.4p.'

Based on Carroll’s estimates, Fevertree trades on a prospective price-to-earnings ratio north of 57 times. ‘We believe the valuation remains full although we expect the share to gain back some of the recent lost
ground’, writes Carroll.

‘The key point for us looking forward now is assessing the strength of momentum alongside the leverage potential with today’s upgrade achieved with a lower level of market spend than expected.

'This could suggest stronger profitability than is currently suggested in consensus expectations ahead of the delivery of strong than expected revenue growth. For now we retain our hold recommendation.'

[Read the whole article here]: